Compare HERE & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HERE | RPID |
|---|---|---|
| Founded | 2019 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.1M | 84.8M |
| IPO Year | 2022 | 2021 |
| Metric | HERE | RPID |
|---|---|---|
| Price | $1.90 | $1.26 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 17.0K | ★ 195.5K |
| Earning Date | 06-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 2.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,587,000.00 |
| Revenue This Year | N/A | $19.12 |
| Revenue Next Year | $79.29 | $18.42 |
| P/E Ratio | $2.83 | ★ N/A |
| Revenue Growth | N/A | ★ 19.74 |
| 52 Week Low | $1.50 | $1.29 |
| 52 Week High | $5.80 | $4.94 |
| Indicator | HERE | RPID |
|---|---|---|
| Relative Strength Index (RSI) | 54.23 | 20.95 |
| Support Level | $1.81 | N/A |
| Resistance Level | $1.95 | $2.18 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 89.03 | 7.84 |
Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.
Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.